Filing Details
- Accession Number:
- 0000902664-16-005447
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-10 16:32:16
- Reporting Period:
- 2016-02-08
- Filing Date:
- 2016-02-10
- Accepted Time:
- 2016-02-10 16:32:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651308 | Beigene Ltd. | BGNE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1510589 | Hillhouse Capital Management, Ltd. | Cayman Corporate Centre, 3Rd Floor 18 Fort Street Grand Cayman E9 00000 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2016-02-08 | 30,626,779 | $0.00 | 30,626,779 | No | 4 | C | Indirect | See footnotes |
Ordinary Shares | Acquisiton | 2016-02-08 | 9,100,000 | $0.00 | 39,726,779 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Series A Preferred Shares | Acquisiton | 2016-02-08 | 14,814,814 | $0.00 | 14,814,814 | $0.00 |
Ordinary Shares | Series A-2 Preferred Shares | Acquisiton | 2016-02-08 | 15,811,965 | $0.00 | 15,811,965 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The securities to which this filing relates are held directly by (i) Hillhouse BGN Holdings Limited, a Cayman Islands limited partnership ("BGN"), (ii) Gaoling Fund, L.P., an exempted Cayman Islands limited partnership ("Gaoling") and (iii) YHG Investment, L.P., an exempted Cayman limited partnership ("YHG" and together with BGN and Gaoling, the "Hillhouse Entities"). BGN is owned by Hillhouse Fund II, L.P., a Cayman Islands limited partnership ("Funds II"). Hillhouse Capital Management, Ltd., an exempted Cayman Islands company ("Hillhouse Capital" or the "Reporting Person"), acts as the sole management company of Fund II and Gaoling and the sole general partner of YHG. Mr. Lei Zhang may be deemed to have controlling power over Hillhouse Capital. Mr. Lei Zhang disclaims beneficial ownership of all of the securities held by the Hillhouse Entities, except to the extent of his pecuniary interest therein.
- The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
- The Series A Preferred Shares were held by BGN and were convertible at any time, at the holder's election, into Ordinary Shares of the Issuer. The Series A Preferred Shares did not have an expiration date. The Series A Preferred Shares automatically converted into Ordinary Shares upon the closing of the Issuer's initial public offering.
- The Series A-2 Preferred Shares were held by BGN and were convertible at any time, at the holder's election, into Ordinary Shares of the Issuer. The Series A-2 Preferred Shares did not have an expiration date. The Series A-2 Preferred Shares automatically converted into Ordinary Shares upon the closing of the Issuer's initial public offering.
- These Ordinary Shares represented by American Depositary Shares ("ADSs") were purchased in the Issuer's initial public offering at a price of $24.00 per ADS.
- Each ADS represents 13 Ordinary Shares.
- These Ordinary Shares are represented by an aggregate of 700,000 ADSs held by Gaoling and YHG.